These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 713245)

  • 1. [Pathogenesis of blood coagulation disorders in coronary arteriosclerosis].
    Ermolaev VV; Sytnikova IA
    Kardiologiia; 1978 Oct; 18(10):132-3. PubMed ID: 713245
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart].
    Furkalo NK; Dukhina MA; Bol'shakova RM; SolovtsovA KM; Progonnaia
    Kardiologiia; 1976 Dec; 16(12):32-40. PubMed ID: 1011479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution].
    Liusov VA; Soboleva VN; Katyshkina NI
    Kardiologiia; 1985 Sep; 25(9):63-7. PubMed ID: 4079228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure].
    Panchenko EP
    Kardiologiia; 1981 Aug; 21(8):50-5. PubMed ID: 7289383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis].
    Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G
    Riv Crit Clin Med; 1968; 68(3):211-37. PubMed ID: 5737876
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
    Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of thrombophilic syndromes. II. Preliminary research on the behavior of the plasmatic inhibitor of the product of the contact reaction in coronary, cerebral and peripheral arteriosclerosis].
    Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G
    Riv Crit Clin Med; 1968; 68(4):289-323. PubMed ID: 5746286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the indicators of the blood coagulation and fibrinolysis systems in the pre-clinical stage of ischemic heart disease].
    Andreenko GV; Panchenko VM; Lisina AN; Liutova LV
    Kardiologiia; 1978 Oct; 18(10):57-60. PubMed ID: 713256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Paracoagulation" phenomenon and fibrin- fibrinogen degradation products in acute poisoning with acetic acid].
    Kuznetsova AV
    Ter Arkh; 1977; 49(6):139-43. PubMed ID: 898038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
    Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
    Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravascular thrombus formation and problems of laboratory control in coronary insufficiency].
    Lyusow WA; Belousow JB; Parfjenow AS; Sawenkow MP; Pantschenko EP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):176-9. PubMed ID: 6177601
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
    Smith EB
    Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the blood coagulation system after surgeries on abdominal aortic aneurysms].
    Nikul'nikov PI; Liksunov OV; Ratushniuk AV; Lugovs'koĭ EV; Kolesnikova IM; Lytvynova LM; Kostiuchenko OP; Chernyshenko TM; Hornyts'ka OV; Platonova TM
    Klin Khir; 2012 Sep; (9):32-6. PubMed ID: 23285650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombelastogram in patients with coronary arteriosclerosis and auricular fibrillation].
    Tereshchenko OI
    Vrach Delo; 1974 Nov; 0(11):78-9. PubMed ID: 4432481
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble fibrin complexes in coronary disease.
    Anaya-Galindo R; Shattil SJ; Shelburne JC; Colman RW
    Thromb Res; 1976 Aug; 9(2):153-65. PubMed ID: 788221
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative immunoenzyme method for determining fibrin-fibrinogen degradation products in the blood].
    Ermolin GA; Liusov VA; Panchenko EP
    Lab Delo; 1984; (1):11-5. PubMed ID: 6199554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
    Pliutto AM
    Lab Delo; 1974; 8(0):465-8. PubMed ID: 4139365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.